These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7154916)

  • 21. Thrombin generation test in patients under anticoagulant therapy with vitamin K antagonists.
    Brocal I; Marco P; Lucas J; Verdú J; Tarín F
    Thromb Haemost; 2009 Mar; 101(3):594-5. PubMed ID: 19277428
    [No Abstract]   [Full Text] [Related]  

  • 22. Oral anticoagulant therapy and international normalized ratios in swine.
    McGlasson DL; Brickey DA; Doe RH
    Lab Anim Sci; 1998 Aug; 48(4):371-3. PubMed ID: 10090045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring oral anticoagulation may require determination of single coagulation factor activities in patients with antiphospholipid syndrome.
    Sucker C; Wenzel F; Zotz RB; Hetzel GR; Scharf RE
    J Rheumatol; 2006 Sep; 33(9):1881-2. PubMed ID: 16881092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amidolytic determination of Factor X in clinical plasma samples.
    Robijns P; Lijnen HR; Collen D
    Acta Clin Belg; 1983; 38(5):289-94. PubMed ID: 6659834
    [No Abstract]   [Full Text] [Related]  

  • 25. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
    Kim YS; Murkin JM; Adams SJ
    Heart Surg Forum; 2004; 7(6):E599-604. PubMed ID: 15769695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Quality control in the coagulation laboratory with special reference to conventional methods for control of oral anticoagulant therapy].
    Paar D
    Med Lab (Stuttg); 1981; 34(3):83-7. PubMed ID: 7231352
    [No Abstract]   [Full Text] [Related]  

  • 27. Turning aptamers into anticoagulants.
    Famulok M
    Nat Biotechnol; 2004 Nov; 22(11):1373-4. PubMed ID: 15529158
    [No Abstract]   [Full Text] [Related]  

  • 28. Accuracy of capillary whole blood international normalized ratio on the CoaguChek S, CoaguChek XS, and i-STAT 1 point-of-care analyzers.
    Karon BS; McBane RD; Chaudhry R; Beyer LK; Santrach PJ
    Am J Clin Pathol; 2008 Jul; 130(1):88-92. PubMed ID: 18550476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Lupus anticoagulant screening: comparison of 5 tests (author's transl)].
    Follea G; Ffrench P; Trzeciak MC; Dechavanne M
    Nouv Rev Fr Hematol (1978); 1981; 23(4):203-7. PubMed ID: 7312614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre-operative management of patients on drugs affecting blood coagulation.
    Dabrowski P; Orlicz-Szczesna G
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):278-81. PubMed ID: 16145996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined coagulation phase-directed factor Xa inhibition with heparin compounds and DX-9065a - a direct and selective antagonist.
    Becker RC; Alexander J; Li YF; Bovill E; Spencer FA; Robertson TL; Kunitada S; Dyke CK; Harrington RA
    Thromb Haemost; 2004 Dec; 92(6):1229-31. PubMed ID: 15622616
    [No Abstract]   [Full Text] [Related]  

  • 32. [A basic study on a highly sensitive automated method for hypercoagulable state in plasma, fluorogenic prothrombin time (FPT) method].
    Ohki M; Tanaka S; Uchida K; Yamaguchi T; Kato H
    Rinsho Byori; 1993 Oct; 41(10):1153-8. PubMed ID: 8254961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring anticoagulant therapy by measuring haemostatic parameters.
    Chek JB
    East Afr Med J; 1997 Jan; 74(1):1-2. PubMed ID: 9145566
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term patient self-management of oral anticoagulation.
    Ansell JE; Patel N; Ostrovsky D; Nozzolillo E; Peterson AM; Fish L
    Arch Intern Med; 1995 Nov; 155(20):2185-9. PubMed ID: 7487240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factor X deficiency in a cat.
    Gookin JL; Brooks MB; Catalfamo JL; Bunch SE; Muñana KR
    J Am Vet Med Assoc; 1997 Sep; 211(5):576-9. PubMed ID: 9290823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Extended oral anticoagulation. "Self-managers" live with less risk].
    MMW Fortschr Med; 2003 Oct; 145(44):46. PubMed ID: 14655511
    [No Abstract]   [Full Text] [Related]  

  • 37. Magnetoelastic transducers for monitoring coagulation, clot inhibition, and fibrinolysis.
    Puckett LG; Lewis JK; Urbas A; Cui X; Gao D; Bachas LG
    Biosens Bioelectron; 2005 Mar; 20(9):1737-43. PubMed ID: 15681188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Coagulation self-control after valve replacement. Stable anticoagulation permits lowering of the intensity].
    MMW Fortschr Med; 2004 Apr; 146(14):44. PubMed ID: 15344756
    [No Abstract]   [Full Text] [Related]  

  • 39. Acquired factor X deficiency in a Negro boy.
    Bayer WL; Curiel D; Szeto IL; Lewis JH
    Pediatrics; 1969 Dec; 44(6):1007-9. PubMed ID: 5365045
    [No Abstract]   [Full Text] [Related]  

  • 40. The discovery of factor X: a personal reminiscence.
    Bachmann F
    Thromb Haemost; 2007 Jul; 98(1):16-9. PubMed ID: 17597984
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.